NCT07085767

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2025-11-03Est. Completion: 2028-12

Enrollment target: 1,000 participants

Locations

Clinical Trial Site, Hot Springs, Arkansas, United States
Clinical Trial Site, Beverly Hills, California, United States
Clinical Trial Site, San Francisco, California, United States
Clinical Trial Site, Santa Barbara, California, United States
Clinical Trial Site, Aurora, Colorado, United States
Clinical Trial Site, Denver, Colorado, United States
Clinical Trial Site, New Haven, Connecticut, United States
Clinical Trial Site, Tampa, Florida, United States
Clinical Trial Site, Marietta, Georgia, United States
Clinical Trial Site, Honolulu, Hawaii, United States
Clinical Trial Site, Peoria, Illinois, United States
Clinical Trial Site, Urbana, Illinois, United States
Clinical Trial Site, Ames, Iowa, United States
Clinical Trial Site, Scarborough, Maine, United States
Clinical Trial Site, Annapolis, Maryland, United States
Clinical Trial Site, Minneapolis, Minnesota, United States
Clinical Trial Site, Kansas City, Missouri, United States

Other microbiome trials you might be interested in

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung CancerPhase 3Recruiting

Advanced Lung Non-Squamous Non-Small Cell CarcinomaMetastatic Lung Non-Squamous Non-Small Cell CarcinomaRecurrent Lung Non-Squamous Non-Small Cell CarcinomaStage IIIB Lung Cancer AJCC v8Stage IV Lung Cancer AJCC v8

This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatm…

Anchorage, United StatesEst. completion Dec 31, 2026

View Trial →

Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-Up StudyCompleted

Breast Cancer

This study will explore new screening methods for early detection of breast and ovarian cancer in women at high risk for…

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.